[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Product Landscape, 2021

April 2021 | 30 pages | ID: C46D94F381CDEN
GlobalData

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Product Landscape, 2021

SUMMARY

GlobalData's Medical Devices sector report, “Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Resynchronisation Therapy - Defibrillator uses an Implantable Cardioverter Defibrillator (ICD) to improve the coordination of the heart rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
3.2 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
3.3 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
3.4 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date

4 CARDIAC RESYNCHRONISATION THERAPY - DEFIBRILLATORS (CRT-D) - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
4.2 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development

5 CARDIAC RESYNCHRONISATION THERAPY - DEFIBRILLATORS (CRT-D) COMPANIES AND PRODUCT OVERVIEW

5.1 Boston Scientific Corp Company Overview
5.2 IRadimed Corp Company Overview
5.3 Johns Hopkins University Company Overview
5.4 Mayo Clinic Company Overview
5.5 Medtronic Plc Company Overview
5.6 MicroPort CRM SA Company Overview
5.7 NewPace Ltd Company Overview

6 CARDIAC RESYNCHRONISATION THERAPY - DEFIBRILLATORS (CRT-D)- RECENT DEVELOPMENTS

6.1 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.2 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.3 Feb 03, 2021: Nihon Kohden provides Consolidated Financial Highlights for the Third Quarter of FY2020 (From April 1, 2020 to December 31, 2020)
6.4 Sep 17, 2020: CIRSE 2020: New clinical data support use of 4-french devices for ambulatory pad treatment
6.5 Jun 29, 2020: LivaNova to Host Conference Call for Second Quarter 2020 Results
6.6 Jun 04, 2020: Vital Defibrillator donated to first responders
6.7 May 07, 2020: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2020
6.8 Apr 24, 2020: FDA lifts injunction on manufacture and distribution of Philips’ defibrillators in the US
6.9 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Next Generation Quad Polar CRT-D - Product Status
Next Generation Quad Polar CRT-D - Product Description
NG3 Non Quad System - Product Status
NG3 Non Quad System - Product Description
Resonate 2.0 - Product Status
Resonate 2.0 - Product Description
IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
MR Defibrillator - Product Status
MR Defibrillator - Product Description
Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Cardiac Arrhythmia Termination Device - Product Status
Cardiac Arrhythmia Termination Device - Product Description
Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Atrial Fibrillation Device - Product Status
Atrial Fibrillation Device - Product Description
Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
MRI Safe CRT-D - Product Status
MRI Safe CRT-D - Product Description
Next Gen ICD And CRT-D - Product Status
Next Gen ICD And CRT-D - Product Description
MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview
Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Status
Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Description
NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
The Implantable Subcutaneous String Defibrillator (ISSD) - Product Status
The Implantable Subcutaneous String Defibrillator (ISSD) - Product Description
Glossary

LIST OF FIGURES

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date


More Publications